Quantcast

Latest Cepheid variable Stories

2011-05-19 14:21:00

LOUISVILLE, K.Y., May 19, 2011 /PRNewswire/ -- Laboratory Supply Company (LABSCO), the largest privately held supplier of diagnostic instrumentation and clinical laboratory products to hospitals, physician office laboratories, reference labs and other non-acute care settings in the United States, announced today it has entered into an agreement with Cepheid (NASDAQ: CPHD) to become Cepheid's exclusive distribution partner for its GeneXpert® Systems and tests in the US...

2011-05-18 06:00:00

SUNNYVALE, Calif., May 18, 2011 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced it has entered into an agreement with LABSCO (www.labsco.com), the largest privately held distributor of clinical products in the United States, to become its US distribution partner for Cepheid's GeneXpert® Systems and tests. The agreement grants LABSCO exclusive US distribution rights to the acute care hospital market for institutions with less than 150 beds. The agreement does not...

2011-05-12 15:05:00

SUNNYVALE, Calif., May 12, 2011 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast. Jefferies Global Healthcare Conference, New York, NY Tuesday, June 7, 2011 at 12:15 p.m. Eastern Time Goldman Sachs Global Healthcare Conference, Rancho Palos Verdes, CA Wednesday, June 8, 2011 at 9:20 a.m....

2011-04-11 06:00:00

SUNNYVALE, Calif., April 11, 2011 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Xpert® C. difficile/Epi test. Cepheid's first Xpert C. difficile test has been available in the United States since July 2009. The test's unique combination of high sensitivity and rapid turnaround time has quickly established Xpert C. difficile as the molecular market leader. Building on the...

2011-03-15 15:10:00

SUNNYVALE, Calif., March 15, 2011 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that Glenn Steele, Jr., MD, PhD, has been nominated for election to Cepheid's Board of Directors at the company's Annual Meeting of Shareholders to be held on April 26, 2011. Dr. Steele has been President and Chief Executive Officer of Geisinger Health System, a physician-led health care system serving multiple regions of Pennsylvania, since 2001. Before that, Dr. Steele served as the Richard T....

71883f4c7bc50f91ff4df3e72baf4f80
2011-03-02 06:45:00

This image of NGC 247, taken by the Wide Field Imager on the MPG/ESO 2.2-meter telescope at ESO's La Silla Observatory in Chile, reveals the fine details of this highly inclined spiral galaxy and its rich backdrop. Astronomers say this highly tilted orientation, when viewed from Earth, explains why the distance to this prominent galaxy was previously overestimated. The spiral galaxy NGC 247 is one of the closest spiral galaxies of the southern sky. In this new view from the Wide Field Imager...

2011-01-13 06:00:00

SUNNYVALE, Calif., Jan. 13, 2011 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2010 fourth quarter and full year ended December 31, 2010, on Thursday, January 27, 2011, after the close of the market. The company will host a management presentation at 2 p.m. Pacific Time on Thursday, January 27, 2011, to discuss the results. To access the live webcast, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes...

2010-12-23 15:05:00

SUNNYVALE, Calif., Dec. 23, 2010 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that its executives will be speaking at the following investor conference, and invited investors to participate via webcast. J. P. Morgan Healthcare Conference Thursday, January 13, 2011 at 11.00 a.m. Pacific Time To access the live webcast for this event, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the...

2010-10-07 15:05:00

SUNNYVALE, Calif., Oct. 7 /PRNewswire/ -- Cepheid today announced an exclusive collaboration with Novartis for the commercialization of a test for monitoring the BCR-ABL gene transcript in peripheral blood specimens from patients diagnosed with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). Together with other lab tests, monitoring levels of BCR-ABL transcripts in Ph+ CML patients will aid in patient management. The collaboration reflects the commitment shared by...

2010-10-07 15:02:00

SUNNYVALE, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Cepheid today announced that it will report financial results for its third quarter ended September 30, 2010, on Thursday, October 21, 2010, after the close of the market. The company will host a management presentation at 2 p.m. Pacific Time on Thursday, October 21, 2010, to discuss the results. To access the live webcast, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to...


Latest Cepheid variable Reference Libraries

3_3fe163858980bcaf7ae60a0ecf315c192
2004-10-19 04:45:40

Andromeda Galaxy -- The Andromeda Galaxy, also known as M31, or the object 31 on the catalog of Messier, is the other giant spiral galaxy in the Local Group, together with our galaxy, the Milky Way. It is at a distance of approximately 2.36 million light years or 725 kpc, in the direction of the constellation Andromeda, and it will probably merge in the future with our galaxy, to form a giant elliptical. With a mass of about 1.5 times more than the Milky Way, it is the dominant galaxy...

More Articles (1 articles) »
Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related